Please login to the form below
Darwin's Medicine blog
Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School.
Pfizer's basic instincts 
Relics from the past20 Jan 2021
Terms that were once perfectly descriptive now only serve to tell us how the world has changed
Chaperone Leadership 18 Dec 2020
An insightful parallel between bosses and biology
The chief executive ostrich 25 Nov 2020
Some of the most perplexing executive behaviour is simply Darwinian
Bayer's drop of the future26 Oct 2020
Digital health isn’t always about digital
Stop that!24 Sep 2020
You might think better if you were less of a scientist
Socially distanced strategising07 Aug 2020
The new normal can improve how you create strategy
We've got this!26 Jun 2020
Our industry has evolved before and we will again
Evolving at home28 May 2020
How we work from home will evolve in a Darwinian way, too
Covidian selection27 Apr 2020
COVID-19 will trigger a spurt of change in the life sciences industry and, perhaps, a brighter future
COVID-19 Updates and Daily News
Featured jobs
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- GSK launches late-stage testing of RSV vaccine candidate in older adults
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Sinovac’s COVID-19 vaccine appears safe in older adults
- bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
- FDA schedules meeting on 26 February to review J&J’s one-dose COVID-19 vaccine
- FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
- UK introduces Rare Diseases Framework to improve the lives of people with rare diseases
- Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease
- UPDATED: Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
- Merck to acquire Pandion Therapeutics for $1.85bn
- bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
PMHub
Purple Agency
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....
Latest intelligence
- 4 ways to recruit Alzheimer’s disease patients for your clinical trial
- What key things do you need to remember to reach patients living with Alzheimer’s disease?...
- Integrating competitive intelligence into business development, licensing and M&A strategy
- The advantages of partnering with a competitive intelligence or knowledge management team...
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
Quick links
Infographics
